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Objective: Basic fibroblast growth factor is among the most potent promoters of
angiogenesis. Its ability to enhance the blood supply to ischemic airways or
nonvascularized tracheal autograft has been demonstrated. Its cumulative effect
with muscular wrapping and its efficacy in a noncanine large animal model remain
unknown. Treatment with basic fibroblast growth factor and muscular wrapping
were compared with no special treatment and with muscular wrapping alone in an
ovine tracheal autotransplantation model.
Methods: All sheep underwent orthotopic tracheal transplantation with 5 to 8 ring
autografts in the cervical trachea. Fifteen sheep were classified randomly into the
following three groups: no treatment (group A, n  5), muscular wrapping with the
right sternomastoid muscle (group B, n  5), and topical administration of fibrin
glue enriched with 2 g/cm2 basic fibroblast growth factor (group C, n  5).
Results: Devascularized tracheal autografts were unable to maintain their structural
integrity without other treatment (group A). However, the grafts were surrounded by
well-vascularized connective tissue. In the muscular wrapping group (group B),
infections occurred around the grafts, and the muscular wrapping was subject to
necrosis. No neovascularization of the grafts occurred. Therapy with basic fibroblast
growth factor (group C) led to improved muscular wrapping circulation and to
adherence to the tracheal stumps. However, no success was achieved in validating
the circulation in the grafts.
Conclusions: In contrast to the results achieved by other authors with canine models,
the neovascularization of tracheal autografts was not achieved in sheep with the
topical administration of basic fibroblast growth factor. Cranially pediculated mus-
cular wrapping led to poorer circulation in the tissue around the graft than did no
therapy at all.
Primary neoplasia, secondary tumors that have grown into the trachea,and severe tracheal trauma are rare but dangerous conditions. Dyspneaor hemorrhage may force the introduction of surgical therapy. In theevent of long-segment resections in excess of 6 cm, tracheal trans-plantation would prove advantageous.1 Nearly every type of materialhas been used for tracheal grafts. Three types of replacements can be
found: prosthetic materials, organic grafts (both autografts and homografts), and
combinations of both.2 Experimental investigations in small test animals have
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provided partially satisfactory results; as a result of the more
rapid metabolism and better healing in these small animals,
however, the techniques can be applied to large animals or
even human beings only in a limited manner. Regardless of
the method used to reduce the immunogenicity of allogeneic
grafts, successful autotransplantation is a prerequisite for
attempts at allogeneic transplantation. Successful tracheal
autotransplantation in large animals has recently been re-
ported by several study groups.3,4 The promotion of neo-
vascularization with basic fibroblast growth factor (bFGF)
appears particularly promising because it is both simple and
safe. In comparison with such extensive surgical procedures
as omentoplasty, laparotomy, and possibly even sternot-
omy, this treatment presents a clear advantage. bFGF is one
of the most potent promoters of angiogenesis. It has been
shown that bFGF may enhance the blood supply in rats,5
rabbits,6 and dogs.3,7
Many investigations regarding tracheal transplantation
have been carried out with canine models. In dogs, longi-
tudinal vessels are present on the reverse of the trachea;
such vessels are not present in the same way in human
beings. In addition, dogs are proving increasingly difficult
to obtain as study animals and are expensive to buy and look
after. We recently reported on a large animal model involv-
ing sheep for tracheal surgery.8 This study was undertaken
to assess the efficacy of human recombinant bFGF in an
ovine tracheal autotransplantation model.
Material and Methods
Animals and Anesthesia
All operations were performed on 9-month-old female sheep
weighing 40 to 50 kg. The study was approved by the animal care
and use committees at the university and at the local district
government (Ts No.: 509i-42502-00/288). The sheep were system-
ically healthy according to physical examination. Food was with-
held for 24 hours. All animals received humane care in compliance
with the “Principles of Laboratory Animal Care” formulated by the
National Society for Medical Research and the “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996. Anesthe-
sia was induced by intravenous injection of 0.2 mg/kg midazolam
and 7 to 8 mg/kg propofol. The sheep were intubated with a cuffed
endotracheal tube (inner diameter 9.0 mm, length 55 cm; Bivona
Medical Technologies, Gary, Ind), and a stomach tube was in-
serted into the rumen. Anesthesia was maintained with isoflurane
at 2% to 2.5% end-tidal concentration in oxygen (2 L/min). In case
of jet ventilation, anesthesia was maintained with intravenously
administered propofol, and PO2 and PCO2 were measured contin-
uously through an arterial catheter in the carotid artery (Para-
trend7; Agilent Technologies, Palo Alto, Calif) (Figure 1, A and
B). Ventilation was controlled to ensure normocapnia. For periop-
erative analgesia, 4 mg/kg carprofen was administered intrave-
nously and 0.6 mg buprenorphine was administered intramuscu-
larly. In addition, the surgical area was injected with 20 mL of
lidocaine hydrochloride. Antibiotic therapy with sustained-release
penicillin was started before the operation.
Surgical Technique of Tracheal Autotransplantation
The skin and subcutaneous tissues were incised laterally from 3 cm
below the larynx, 12 cm in length. The cervical trachea was
exposed by midline separation of the paired strap muscles and
mobilized circumferentially for 8 cm. A 4-cm segment of the
trachea, representing 5 to 8 cartilage rings, was removed. These
autografts were placed in physiologic saline solution at room
temperature for several minutes. Ventilation was continued after a
spiral endotracheal tube was positioned in the lower trachea or by
jet ventilation. The excised segment was then reimplanted in its
original position as an autograft. The upper anastomosis was
performed first with interrupted 4-0 polydioxanone sutures (Ethi-
con, Inc, Somerville, NJ). Full-thickness bites of all layers, usually
around the adjacent cartilaginous rings, with sutures spaced 5 mm
apart were used. Next, the membranous portion and two thirds of
the cartilaginous portion of the lower anastomosis were sutured
similarly. The spiral endotracheal tube or the jet catheter was then
removed from the operative field, and ventilation was continued
through the oral endotracheal tube. The lower anastomosis was
subsequently completed.
Groups and Treatment of Autografts
The 15 study animals were classified randomly into 3 treatment
groups (Table 1).
1. Group A (n  5). No animal in group A underwent
autograft therapy after the tracheal autotransplantation. The strap
muscles were closed with a running polyglactin 910 suture (Vicryl;
Ethicon); subcutaneous tissue and skin were sutured with 4-0
polyglactin 910 and 4-0 poliglecaprone 25 (Monocryl; Ethicon).
The skin was sealed with a thiram spray (Nobecutane).
2. Group B (n  5). Following tracheal autotransplantation,
the right sternomastoid muscle was cranially pediculated. This
pedicle was used to wrap the autograft circumferentially and
encompassed it completely (Figure 1, C). The neck was closed in
the same fashion as in group A.
3. Group C (n  5). The same kind of pediculated sterno-
mastoid muscle as was used in group B was prepared. Again, this
muscle was wrapped around the autograft and fixed with sutures.
Between the muscle and the autograft, topical fibrin glue with
bFGF was administered. The effectivity and optimal dosage of
bFGF in fibrin glue have been extensively examined in previous
studies.3,5-7 A 2-mL portion of fibrin glue (Beriplast P; Aventis
Behring GmbH, Marburg, Germany) consisting of 1 mL fibrinogen
and aprotinin and 1 mL thrombin and calcium chloride was mixed
with 50 g bFGF (Strathmann Biotec AG, Hamburg, Germany)
and distributed between the muscle and the autograft and covering
TABLE 1. Experimental design
Group No. Treatment of tracheal autografts
A (control) 5 None
B 5 Muscle wrapping
C 5 Muscle wrapping and local
administration of bFGF
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the anastomosis region. The dose of bFGF used is comparable to
2 g/cm2 (according to a formula described by Nakanishi and
colleagues.3 A 1-mL portion of thrombin and calcium chloride
(Beriplast P) was used to reconstitute the lyophilized bFGF. This
mixed solution and 1 mL fibrinogen and aprotinin (Beriplast P)
were administered to the graft simultaneously. The outer surfaces
of the autografts, including the anastomoses, were soaked circum-
ferentially with the drugs. Strap muscles, subcutaneous tissues, and
skin were closed as described for group A.
Postoperative Management
The animals were given preoperative antibiotic coverage (intra-
muscular injection of sustained-release penicillin as 1.2 million IU
benzylpenicillin-benzathine plus 300,000 IU benzylpenicillin-pro-
caine; Tardomyocel; Bayer AG, Leverkusen, Germany) and re-
ceived a second antibiotic dose after 48 hours. The sheep were
observed daily for coughing and dyspnea. Coughing was recorded
as absent, as mild if the sheep rarely coughed, as moderate if the
sheep coughed intermittently, or as severe if the sheep coughed
continuously. Dyspnea was recorded as present or not present. The
cervical incisions were evaluated daily for swelling, inflammation,
seroma formation, subcutaneous emphysema, and signs of infec-
tion.
Necropsy
All sheep were killed with an overdose of sodium pentobarbital
(Eutha77; Aventis Pharma AG, Frankfurt am Main, Germany)
according to the planned survival time or because of clinical
evidence of severe dyspnea or local infection. Planned postoper-
ative survival times in each group were 1 week, 2 weeks, 4 weeks,
8 weeks, and 6 months. With the pentobarbital, 25,000 IU heparin
sodium was administered into a central vein. Autopsy was per-
formed immediately after the animal’s death. Barium sulfate at 50
mL (120% weight/volume, Micropaque; Guerbet GmbH, Sulz-
bach, Germany) was injected into the bilateral carotid arteries.
After the tracheal microvessels were filled with the barium sulfate
solution, the tracheal graft, including both anastomotic sites, was
removed. The entire trachea, with the larynx, the grafts, and both
anastomotic sites, was removed. Abnormal necropsy findings were
recorded. The specimens were fixed with 10% natural buffered
formalin for at least 48 hours. After fixation, xeroradiography of
the graft was performed to obtain the microangiogram. All the
fixed grafts were cut longitudinally at the anterior wall, embedded
in paraffin, longitudinally sectioned, and stained with hematoxy-
lin-eosin, Alcian blue, and periodic acid–Schiff. The viability of
the autografts was evaluated by epithelial morphologic examina-
tion and the assessment of submucosal vessels. The percentages of
epithelial, cartilage, and peritracheal tissues contained were doc-
umented. The percentage of necrotic tissue was also determined.
Results
Survival
All sheep survived the operation without any problems. In
the control group (group A, no muscular wrapping and no
bFGF), the animals that were intended to survive for 1 week
(9 days) and 2 weeks were killed according to schedule. The
other animals, which were intended to survive for longer
periods, had to be killed on postoperative days 16, 18, and
22 because of dyspnea and audible respiratory sounds. Ta-
ble 2 reveals a detailed list.
In the group with muscular wrapping (group B), the first
TABLE 2. Survival and graft status
Sequential No.
Scheduled
survival (d)
Achieved
survival
(d)
Mean survival of
sheep dead before
scheduled date (d)
Graft status at time of death
(macroscopic aspect)
Group A (control) 18.6
1 7 9 Mucosal layer intact, cartilage intact
2 14 14 Mucosal necrosis, cartilage intact
3 28 18 Airway stenosis, necrosis
4 56 16 Airway stenosis, necrosis
5 180 22 Mucosal layer intact, abscess with
cartilage collapse
Group B (muscle wrapping) 12.8
1 7 6 Mucosal necrosis, abscess
2 14 14 Mucosal necrosis, abscess perforation
3 28 15 Dissolution, severe airway stenosis
4 56 9 Mucosal necrosis, abscess
5 180 13* Mucosal necrosis, abscess
Group C (wrapping plus bFGF) 12.6
1 7 6 Muscosal layer intact, cartilage intact
2 14 9 Mucosal dissolution, cartilage collapse
3 28 15 Airway stenosis, necrosis
4 56 13* Mucosal dissolution, cartilage collapse
5 180 10 Mucosal necrosis, cartilage intact
For all groups, n  5.
*Died of sudden respiratory failure.
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2 animals, with planned survival times of 1 and 2 weeks,
were also killed according to schedule. The other animals
had to be killed on postoperative days 9 and 15 because of
dyspnea and audible respiratory sounds. One animal died on
day 13.
In the group with muscular wrapping and local bFGF
administration (group C), only the first animal was killed
according to schedule after 1 week. The other animals had
to be killed on postoperative days 9 and 13 because of
dyspnea and audible respiratory sounds. The remaining 2
animals were then killed on postoperative days 10 and 13
without any clinical indications of dyspnea, because no
further successful attempt was expected in this case.
Macroscopic Condition of the Grafts
1. Group A. In the animal that was killed after 1 week,
the graft was securely anchored to the recipient trachea with
its sutures. The rows of sutures were watertight and airtight.
However, the graft had not been integrated by the body in
any way. The peritracheal tissue, which had remained on the
graft’s cartilaginous braces, had perished but not been re-
moved. The graft’s mucous membrane was pale but shiny
and without defects (Figure 2, A). After 14 days the mucous
membrane was dark and livid and had already become
detached in a few small areas. The tracheal graft was still
firmly anchored but had not adhered to the surrounding
tissue (Figure 2, B). The actual graft was firmly encapsu-
lated by a ring of firm connective tissue. The findings in
those animals that were killed during the further course
(postoperative days 16, 18, and 22) were similar. The graft
was encapsulated by firm connective tissue. With time,
however, this connective tissue again became soft, so that it
was able to give during inhalation. The mucous membrane
had perished, and the cartilage had begun to shrink and was
soft (Figure 2, C). This remodeling led to the increasing
stenosis of the respiratory tract during inhalation.
2. Group B. In the animal with a survival time of 1
week, the transplant site was infected. The muscle wrapped
around the graft was predominantly necrotic. No connection
had been achieved between the graft and the muscle. The
graft’s mucous membrane had perished (Figure 2, D). In the
case of the other animals, which had to be killed on days 13,
14, and 15, progressive necrosis of the mucous membrane,
which was partially excoriated, was revealed (Figure 2, E).
The cartilage was soft and also infected. The transplant site
was revealed to be severely infected, and the muscular
wrapping was necrotic.
3. Group C. After 1 week the mucous membrane and
the cartilage in this group was revealed to be macroscopi-
cally intact. The transplant site was not infected. The row of
sutures was impermeable. Part of the muscle had adhered to
the graft. In the next 2 animals, on which necropsies was
performed because of dyspnea 9 and 13 days after trans-
plantation, the mucosa had perished and was partially per-
forated, and the cartilage had broken down (Figure 2, F).
Although the muscle was also partially attached to the graft
in this case no visible neovascularization had been achieved.
In contrast, the muscle at the nontransplanted ends of the
trachea had become firmly integrated. The graft itself was
surrounded by infected fluid. The last 2 animals were then
removed from the study. In each of these animals, the
graft’s mucous membrane had perished and the cartilage
was still predominantly covered. The infection at the trans-
plant site was locally delimited; the muscular wrapping was
partially intact. The cartilage had not yet become softened
(Figure 2, G).
Histologic Examination
Examination with an optical microscope predominantly
confirmed the findings of the macroscopic autopsy. The
details are summarized in Table 3 and Figure 1, D to G. In
the final analysis, the tracheal mucous membrane was ne-
crotic in all animals and at all points in time. Differences
were merely in the degree of desquamation and progressive
destruction. The same was revealed in the case of the
peritracheal tissue. This was also necrotic in all animals and
at all points in time. The differences with regard to decom-
position were significantly dependent on the existence of a
peritracheal infection. In the cartilage, the percentage of
necrosis was determined according to the number of vital
cell nuclei. Clear differences were revealed in this case,
with worse results for pure muscular wrapping, especially in
favor of those animals treated with bFGF.
Microangiography
In group A, the circulation of the connecting tissue around
the tracheal graft was shown to increase with time (Figure 3,
A). Although the circular, intact preparation (Figure 3, A,
after 14 days) gives that impression, the graft itself is not
supplied with blood. Figure 3, B, reveals this in the dis-
sected preparation. Only Figure 3, C, after 22 days, reveals
a cloudy contrast at the edge of the graft. In macroscopic
terms, however, this finding did not correspond to circula-
tion, but rather to the leakage of contrast agent at the edge
of the healthy mucous membrane.
In group B, circulation around the grafts was revealed to
be considerably poorer. As a result of the infected and
partially necrotic muscular wrapping, no relevant circula-
tion was achieved in and around the grafts (Figure 3, D and E).
Group C also did not reveal any graft circulation. Only
an improvement in vascularization at the tracheal stumps
was determined (Figure 3, F). The muscular wrapping was
firmly integrated and vascularized in this location. In the
case of advanced infection around the graft (as in Figure 3,
G), this effect could no longer be detected.
Cardiothoracic Transplantation Behrend, von Wasielewski, Klempnauer
234 The Journal of Thoracic and Cardiovascular Surgery ● August 2002
TX
Figure 1. Intraoperative situation and histologic examination. A, Intraoperative situation during autotransplantation. Posterior wall is
sutured for both proximal and caudal anastomoses. Jet catheter is inserted into distal trachea for ventilation. Catheter is inserted
through right carotid artery for continuous monitoring of PO2, PCO2, pH, and saturation. B, Anastomosis is completed. Arterial cannula
is still in carotid artery. C, After anastomosis, muscular wrapping is carried out with cranially pediculated right sternomastoid muscle.
This is dorsally guided to left to trachea at rear of graft, is wrapped around trachea, and is loosely affixed to itself and to trachea. D,
Optical micrograph of autograft after 14 days (group A; hematoxylin and eosin stain, original magnification 25). Cartilage in left half
of figure belongs to native trachea; cartilage on right belongs to autograft. Mucous membrane of native trachea, coming from left, slowly
makes transition from columnar epithelium to flat metaplasia, which is seated on inflamed tissue. This pseudomucosa slightly covers
exposed graft cartilage on right of figure. Actual mucous membrane of graft cartilage has already completely disappeared. E, Autograft
with muscular wrapping after 6 days (group B; hematoxylin and eosin stain, original magnification 25). Mucous membrane is still
present, as is submucosal tissue, but both are necrotic. Both cartilages belong to graft, and already reveal extensive necrosis,
particularly in comparison with Figure 1, D. F, Autograft with muscular wrapping and bFGF after 10 days (group C; hematoxylin and eosin
stain, original magnification 25). Mucosa is also necrotic but still present in this case. More cartilage is still vital than in Figure 1,
E. G, Same preparation as in Figure 1, F (hematoxylin and eosin stain, original magnification 25). Left cartilage belongs to native
trachea; right cartilage belongs to autograft. In this case mucous membrane also covers inflamed tissue in direction of graft but does
not yet reach gap between two cartilages at this time.
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Figure 2. Macroscopic aspect of grafts. A, Autograft 9 days after transplantation. Rows of sutures and mucous
membrane are intact. Graft’s mucous membrane is not supplied with blood. B, Autograft after 16 days. Necrosis of
graft’s mucous membrane is now clearly visible. However, mucous membrane is still complete and covers
cartilaginous braces. Mucous membrane is beginning to retract at tracheal stumps. C, Autograft after 22 days.
Because of cicatricial shrinkage, graft is increasingly being pushed into lumen. Mucous membrane is not supplied
with blood. Cartilage is beginning to break down. D, Autograft with muscular wrapping after 1 week. Mucous
membrane is not supplied with blood. Rows of sutures are still intact. Graft’s mucous membrane is slowly being
absorbed at edge. E, Autograft with muscular wrapping after 15 days. Graft’s mucous membrane is necrotic and
already partially detached. Healthy mucous membrane is beginning to retract at tracheal stumps, so healthy
cartilaginous braces are also being exposed. Graft’s cartilage is softened, necrotic, and collapsing into lumen;
catastrophic findings. F, Autograft with muscular wrapping and bFGF on day 9. Graft’s mucous membrane is
necrotic and reveals minor perforations. Rows of sutures are still intact. G, Autograft with muscular wrapping and
bFGF on day 10 (before scheduled date). Commencement of cicatricial retraction. Stump mucous membrane is also
retracted. Graft’s mucous membrane is dark, indicating progressive necrosis.
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TABLE 3. Histologically determined degree of necrosis and cell loss
Sequential No.
Survival
(d)
Premature
termination
Epithelial
necrosis (%)
Desquamation
(%)
Cartilage
necrosis (%)
Dissolution
(%)
Peritracheal
graft tissue
necrosis (%)
Dissolution
(%)
Group A 100 100
9 0 50 0 0
14 0 40 0 0
18 Yes 80 70 0 80
16 Yes 100 60 80 100
22 Yes 80 30 100 50
Group B 100 100
6 50 40 0 50
9 Yes 80 30 0 0
15 Yes 100 90 50 100
14 Yes 100 90 70 100
13 Yes 50 80 50 50
Group C 100 100
6 0 20 0 0
9 Yes 50 50 50 50
15 Yes* 20 30 0 20
13 Yes 70 70 50 30
10 Yes* 20 20 0 50
*Premature termination of study because a positive outcome was no longer to be expected.
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Discussion
The replacement of the trachea by transplantation remains
an unsolved problem.9,10 With few exceptions, clinical at-
tempts at allogeneic or alloplastic replacement have re-
mained unsuccessful to date. The main problems in the case
of allogeneic transplantation are the supply of blood to the
graft and immunogenicity. Whereas autografts in small an-
imals are able to heal even without the introduction of
additional measures, this does not apply to large animals or
human beings.11-13 Various procedures for restoring circu-
lation as rapidly as possible are described. Single-stage and
multistage procedures compete with one another in this
case.14,15 Successful procedures involving muscular wrap-
ping3,16 and the greater omentum14,17 have been described.
Cryopreservation,12,13,18-20 detergents,21 and immunosup-
pression22 compete as methods of reducing immunogenic-
ity.
Although muscular wrapping and omental grafting have
been reported as being successful, there is not under any
circumstances any certain guarantee of successful neovas-
cularization. Intensive research into further measures is
therefore being done. One approach is an attempt to directly
promote angiogenesis. Various vascular growth factors, the
efficacies of which have been verified, have been isolated.
Among the angiogenesis factors best investigated to date is
bFGF, a protein with a molecular weight of 17 kd and an
efficacy shown both in vitro and in vivo.23-27 Soon after its
discovery, bFGF was being used in the revascularization of
tracheal grafts.5,6,28
A report regarding the improvement in tracheal auto-
transplantation healing in dogs with bFGF was recently
published.3 In this report, the treatment of the autografts
with bFGF was equivalent to pediculated muscular wrap-
ping or omental grafting. We attempted to reproduce these
results in a cervical autotransplantation model in sheep. On
the basis of the data at hand,3 a group with bFGF without
muscular wrapping was not used. Rather, our goal was to
ascertain whether the effects of bFGF and muscular wrap-
ping were additive or increasing. A negative effect from the
muscle wrapping was not expected.
Cervical autotransplantation without any additional mea-
sure revealed astonishingly good results. A longer survival
time (18.6 days) was achieved than with either muscular
wrapping alone or bFGF with muscular wrapping. The
grafts were ensheathed by firm connective tissue. Good
vascularization of the connective tissue was also revealed,
but no relevant assumption of contact with the grafts oc-
curred, with the results that this tissue became necrotic,
shrank, and finally prolapsed into the lumen. In comparison
with the untreated grafts, simple muscular wrapping with
the sternomastoid muscle was revealed to be inferior. This
result was initially astonishing. Although the muscle was
vital during the operation, certain sections appeared to be-
come necrotic afterward and to become infected through the
obligatorily contaminated trachea. This infection then led to
the total necrosis of the muscle and prevented any neovas-
cularization of the graft. The situation did not improve
considerably when bFGF was administered. In this case the
muscle healed well and firmly with the cranial and caudal
tracheal stumps. However, no considerable graft neovascu-
larization was achieved.
The results clearly show that a unilaterally pediculated
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Figure 3. Microangiography of tracheal grafts. A, Autograft 14 days after transplantation. Trachea has remained circularly intact. Strong
intercartilaginous arteries at intact edges of trachea can clearly be seen. In area of graft, however, vessels are present only in
surrounding connective tissue. Circulation in graft is uncertain. B, Autograft 16 days after transplantation. Also good depiction of
tracheal stumps in this case. Graft has shrunk in longitudinally and transversely. Circulation depicted in area of graft is attributable to
peritracheal connective tissue. C, Autograft 22 days after transplantation. Good circulation is seen in tracheal stumps and around graft.
Graft itself is not supplied with blood. D, Autograft with muscular wrapping (group B) after 15 days. Circulation is present only in healthy
trachea. No circulation can be detected in graft or, because of infected muscular wrapping, in peritracheal tissue. E, Autograft with
muscular wrapping (group B) after 14 days. Again, no circulation is present in either graft or surrounding connective tissue. F, Autograft
with muscular wrapping and bFGF (group C) 7 days after transplantation. Good tracheal stump circulation is present. Particularly on left
(arrow), circulation in attached cicatricial tissue on tracheal stump is also clearly visible. No blood is being supplied to muscular
wrapping or graft. G, Autograft with muscular wrapping and bFGF (group C) after 9 days. Good stump circulation is present. No blood
is being supplied to graft or muscle.
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sternomastoid muscle is not sufficient to vascularize a cer-
vical tracheal autotransplantation. Rather, the muscular
wrapping opens the area to extensive infection. This cannot
be compensated for by the positive effect of the bFGF.
Whether the almost obligatory pulmonary contamination of
the sheep plays a role in this remains unclear. The reason
that certain study groups required extensive intervention to
achieve the same purpose3,7,14,16,17 also remains unclear.
The revascularization of the intrinsic transverse intercarti-
laginous arteries after 7 days appears improbable not only
for the specific situation of the trachea but also for any other
type of nonvascularized autograft.4
Because of the published data,3 we had expected to
achieve an improvement in neovascularization with bFGF.
Contrary to our expectations, the extended preparation of
the cervical muscles with a pediculated sternomastoid mus-
cle led to different results. At the same time, the graft and
the muscular wrapping became infected through the trachea.
A subjective advantage was perceived for the animals
treated with bFGF, but this was difficult to objectify on the
basis of the data presented here.
We have drawn several conclusions from these studies.
In sheep, cervical autografts without any further measures
are ensheathed in well-vascularized connective tissue, but
neovascularization is not achieved before the grafts become
necrotic and relocate the respiratory tract. Unilaterally pe-
diculated muscular wrapping does not promote the circula-
tion sufficiently to facilitate autotransplantation but may
provide a nutritive medium for extensive infections. Addi-
tion of bFGF in fibrin glue considerably improves adhesion
and the cicatricial healing of muscular wrapping, at least in
healthy tracheas.
Our investigation clearly revealed that the results ob-
tained from a given large animal model cannot necessarily
also be transposed to another large animal model.3 There is
no ideal large animal model for tracheal surgery. Individual
animals correspond better or less well to human beings with
regard to individual characteristics. It would therefore ap-
pear sensible to check initially successful experimental in-
vestigations with different large animal models before ini-
tiating clinical studies.
On the basis of these conclusions, we are planning a
similar series of studies in which the respiratory tract will be
temporarily splinted (stented) to allow additional time for
the grafts to heal. At the same time we plan to attempt to
bring the cervical muscles to the graft without pediculating
them over long segments. The purportedly positive results
with bFGF also lead us to continue to attempt to promote
neovascularization with this agent. The distant aim of our
continued investigations remains the cervical transplanta-
tion of primarily nonvascularized, allogeneic tracheas. We
continue to search for a procedure that can be implemented
practically without omentoplasty or laborious plastic sur-
gery. Currently, however, we still lack a large animal model
in which autograft healing can be achieved in a reliable and
reproducible manner.
We thank Wolfgang Schu¨ttler and Ms Eva Kluge, Michall
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